Diabetes
Exclusives
View More
Diabetes Q&A
In this month's column, Andrea Cedeno, MD, and Kim A. Carmichael, MD, answer questions about continuous glucose monitors, the appropriate patient populations, potential adverse reactions, and more.
Risk Management
In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.
What's the Take Home?
A 67-year-old woman is seen in the office a week after a long hospital admission for a variety of diabetes-related complications. She has had diabetes for 30 years, and her management has progressed from dietary changes to a variety of oral antidiabetes agents to, in recent years, injected insulin regimens.
prevention
Prediabetes is recognized as a serious health condition in the United States. In your opinion, should metformin be prescribed to patients with prediabetes to prevent progression to diabetes mellitus?
Treatment
In this “Test Your Knowledge” series, Edward Shahady, MD, asks you to advise a patient about his blood glucose level and use of finger sticks.
